Albert Marchio

Albert Marchio

Algemeen Directeur bij FRESH TRACKS THERAPEUTICS, INC.
74 jaar
Health Technology
Consumer Services
Commercial Services

Profiel

Albert N.
Marchio
is currently the Chairman, CEO, CFO & Secretary at Fresh Tracks Therapeutics, Inc. since 2023.
He is also the Chief Financial & Accounting Officer at NexImmune, Inc. since 2024.
Previously, Mr. Marchio held the position of Treasurer & Vice President at Zoetis Products LLC from 1992 to 2005.
He was the Chief Financial Officer & Executive Vice President at Informed Medical Communications, Inc. from 2008 to 2009.
From 2017 to 2018, he served as the Chief Accounting & Administrative Officer at Edge Therapeutics, Inc. Additionally, he held the position of Treasurer & Vice President at MedPointe, Inc. from 2006 to 2008.
Mr. Marchio also worked as the Vice President & Treasurer at Alpharma LLC from 1992 to 2005.
He was a Managing Operating Partner at Three Fields Capital.
Mr. Marchio holds an MBA from Rutgers State University of New Jersey and an undergraduate degree from Muhlenberg College.

Actieve functies van Albert Marchio

BedrijvenFunctieBegin
FRESH TRACKS THERAPEUTICS, INC. Algemeen Directeur 02-10-2023
NEXIMMUNE, INC. Financieel Directeur/CFO 16-04-2024

Eerdere bekende functies van Albert Marchio

BedrijvenFunctieEinde
Financieel Directeur/CFO 31-10-2017
Financieel Directeur/CFO 01-10-2009
Treasurer 01-01-2008
Treasurer 01-01-2005
Treasurer 01-01-2005
Ervaring van Albert Marchio in detail bekijken

Opleiding van Albert Marchio

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

56

Eerstegraads connecties

10

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit10

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Services

Health Technology

Health Technology

  1. Beurs
  2. Insiders
  3. Albert Marchio
DE LAATSTE UREN | -40 %: De beste tools voorbehouden aan abonnees om de beste beleggingen van morgen te identificeren!
d
:
:
PROFITEER NU